Innovation Pharmaceuticals Inc (IPIX)

[rule_rationale]

Right, not Kevetrin success, but success that Kevetrin is doing something in humans. The question is - can such a PR have more benefit than risk to DF/BI? If the answer to that question is 'Yes, the benefit outweighs the risk' then I would expect to see a PR. Can someone make a business case for releasing that info early, that is how I would determine if I expected to see an early PR. I just don't have the experience in the field to understand if the business case exists for an early PR, if anyone does - please share.